FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Giacomin Jon L 		2. Issuer Name and Ticker or Trading Symbol

CARDINAL HEALTH INC [ CAH ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
CEO, Pharmaceutical Segment
(Last)          (First)          (Middle)

7000 CARDINAL PLACE 		3. Date of Earliest Transaction (MM/DD/YYYY)

8/15/2016
(Street)

DUBLIN, OH 43017
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares   8/15/2016     A (1)    11420   A $0   44598   D    
Common Shares   8/15/2016     F (2)    4013   D $83.60   (3) 40585   D    
Common Shares   8/16/2016     M    13654   A $27.29   54239   D    
Common Shares   8/16/2016     M    16100   A $27.29   70339   D    
Common Shares   8/16/2016     M    9927   A $30.94   80266   D    
Common Shares   8/16/2016     S    47251   D $82.77   (4) 33015   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)   $83.19   8/15/2016     A      56814         (5) 8/15/2026   Common Shares   56814.0   $0   56814   D    
Employee Stock Option (right to buy)   $27.29   8/16/2016     M         13654      (6) 9/15/2016   Common Shares   13654.0   $0   0   D    
Employee Stock Option (right to buy)   $27.29   8/16/2016     M         16100      (7) 9/15/2016   Common Shares   16100.0   $0   0   D    
Employee Stock Option (right to buy)   $30.94   8/16/2016     M         9927      (8) 8/16/2017   Common Shares   9927.0   $0   0   D    

Explanation of Responses:
( 1)  Grant of restricted share units ("RSUs") that vest in three equal annual installments beginning on August 15, 2017.
( 2)  Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 5,254 RSUs and 6,878 performance share units.
( 3)  Reflects closing price on prior business day.
( 4)  The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.70 to $82.96, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.
( 5)  Stock option vests in three equal annual installments beginning on August 15, 2017.
( 6)  The option, representing a right to purchase a total of 48,981 shares, vested and became exercisable in three equal annual installments beginning on September 15, 2010.
( 7)  The option, representing a right to purchase a total of 46,649 shares, vested and became exercisable in three equal annual installments beginning on September 15, 2010.
( 8)  The option, representing a right to purchase a total of 9,927 shares, vested and became exercisable in three equal annual installments beginning on August 16, 2011.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Giacomin Jon L
7000 CARDINAL PLACE
DUBLIN, OH 43017

CEO, Pharmaceutical Segment

Signatures
/s/ Elaine S. Natsis, Attorney-in-fact 8/17/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Cardinal Health (NYSE:CAH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cardinal Health Charts.
Cardinal Health (NYSE:CAH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cardinal Health Charts.